Biolife Science QLD Limited
Records under this name other than the patents Biolife Science QLD Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 3 of 3 · Back to Biolife Science QLD Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,852,604 | Multiepitope Vaccine for Her2/Neu-Associated Cancers Lapsed on the fee record Ended Oct 7, 2026 · High confidence | Lapsed on the fee record | Ended Oct 7, 2026 | High confidence |
| US 7,348,010 | Vaccine Against Cancer Diseases That Are Associated with the HER-2/NEU Oncogene Term ended Term ended Apr 17, 2023 · High confidence | Term ended | Term ended Apr 17, 2023 | High confidence |
| US 7,166,694 | Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells Term ended Term ended Aug 19, 2022 · USPTO record | Term ended | Term ended Aug 19, 2022 | USPTO record |